NYU Langone Health: Hair Growth Drug Safe at Low Doses for Breast Cancer Patients
December 10, 2024
December 10, 2024
NEW YORK, Dec. 10 (TNSres) -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
The hair loss that can occur from chemotherapy sometimes causes enough distress for some women to lose self-confidence, which experts say may discourage them from seeking chemotherapy in the first place.
Oral minoxidil is a commonly prescribed treatment for hair loss. The drug is also the active ingredient in the over-the-c . . .
The hair loss that can occur from chemotherapy sometimes causes enough distress for some women to lose self-confidence, which experts say may discourage them from seeking chemotherapy in the first place.
Oral minoxidil is a commonly prescribed treatment for hair loss. The drug is also the active ingredient in the over-the-c . . .